Kolexia
Vidal Vincent Radio-diagnostic
Vidal Vincent
Radio-diagnostic
Hôpital La Timone
Marseille, France
176 Activités
174 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémorroïdes Hémorragie Sarcomes Hyperplasie de la prostate Carcinomes Tumeurs du foie Carcinome hépatocellulaire Hyperplasie Sarcome d'Ewing

Collaborateurs

Voir plus
Bartoli Jean-Michel
Bartoli Jean-Michel
Hôpital La Timone, Marseille, France
Gaubert Jean-Yves
Gaubert Jean-Yves
Hôpital La Timone, Marseille, France
Tradi Farouk
Tradi Farouk
Hôpital La Timone, Marseille, France
Jacquier Alexis
Jacquier Alexis
Hôpital La Timone, Marseille, France

Industries

Voir plus
GE Healthcare
20 collaboration(s)
Dernière en 2023
Boston Scientific
8 collaboration(s)
Dernière en 2023
Cook France SARL
3 collaboration(s)
Dernière en 2022
Medtronic
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Feasibility of the FairEmbo Concept to Treat Women Postpartum Hemorrhage: Embolization with Suture Fragments.
Cardiovascular and interventional radiology   19 décembre 2023
Expanding the Horizons of Interventional Radiology: Training Analog Astronauts for Percutaneous Drainage in Preparation for Deep Space Exploration.
Cardiovascular and interventional radiology   07 décembre 2023
#CIRSEtakeover with Dr. Vincent Vidal Day 1 in Yaounde ... - Facebook
Facebook   28 novembre 2023
#CIRSEtakeover with Dr. Vincent Vidal Day 1 in Yaounde ... - Facebook
Facebook   28 novembre 2023
REGOBONE: A Randomized Phase II, Placebo-controlled, Multicenter Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Essai Clinique (Unicancer)   06 novembre 2023
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
British journal of cancer   01 novembre 2023
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial.
The Lancet regional health. Europe   26 juin 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study.
ESMO open   06 juin 2023
Bringing Interventional Radiology to Mars!
Cardiovascular and interventional radiology   14 mars 2023
FairEmbo Concept for Postpartum Hemorrhage: Evaluation of the Efficacy of Suture Fragment Compared with Gelatin Sponge Torpedo Embolization in a Post-Gravid Swine Model.
Journal of personalized medicine   07 janvier 2023